American Society for Microbiology, Microbiology Spectrum, 2(9), 2021
DOI: 10.1128/spectrum.00481-21
Full text: Download
This study takes a major next step toward practical application of a novel pharmacodynamic marker that we believe will have transformative implications for tuberculosis. This article follows our recent report in Nature Communications that an assay called the rRNA synthesis (RS) ratio indicates the treatment-shortening of drugs and regimens.